Procurement Summary
Country: Brazil
Summary: Digestive and Respiratory Medications. (The Specifications, Technical Justifications and Needs Contained in the Document in the Terms of Reference will Prevail, as Provided for in Item 6.11 of the Notice).
Deadline: 26 Jun 2026
Posting Date: 11 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143108584
Document Ref. No.: 90309/2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Object: Electronic Auction - Digestive and respiratory medicines. (The specifications, technical justifications and needs contained in the Document in the Terms of Reference will prevail, as provided for in item 6.11 of the Notice). UASG code: 930404 Notice from: 06/11/2026 from 08:00 to 16:30 Proposal Delivery: from 06/11/2026 at 08:00 ACETYLCYSTEINE, DOSAGE 100 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 28463 ACETYLCYSTEINE, DOSAGE 100 MG/ML, PHARMACEUTICAL FORM SOLUTION INJECTABLE Quantity: 9487 ACETYLCYSTEINE, DOSAGE 600 MG, INDICATION POWDER FOR ORAL SOLUTION Quantity: 1080 AMBROXOL, COMPOSITION SALT HYCLORHYDRATE, CONCENTRATION 3 MG/ML, PHARMACEUTICAL SYRUP FORM Quantity: 2260 AMINOPHYLLINE, DOSAGE 24 MG/ML, FORM PHARMACEUTICAL INJECTABLE SOLUTION Quantity: 6490 BISACODIL, DOSAGE 5 MG Quantity: 11380 BROMOPRIDE, DOSAGE 4 MG/ML, DROPS PRESENTATION Quantity: 1260 BROMOPRIDE, DOSAGE 5 MG/ML, INJECTABLE PRESENTATION Quantity: 94470 BROMOPRIDE, DOSAGE 5 MG/ML, INJECTABLE PRESENTATION Quantity: 31490 BUDESONIDE, CONCENTRATION 0.25MG/ML, MEDICATION TYPE SUSPENSION FOR NEBULIZATION Quantity: 450 BUDESONIDE, NASAL AEROSOL PRESENTATION, CONCENTRATION 32MCG/DOSE, ADDITIONAL CHARACTERISTICS BOTTLE WITH VALVE DISPENSER Quantity: 1100 CIMETIDINE, CONCENTRATION 150 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 1800 CAFFEINE, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 1275 CAFFEINE, CONCENTRATION 20 MG/ML, PHARMACEUTICAL FORM INJECTABLE SOLUTION Quantity: 425 DOMPERIDONE, DOSAGE 1 MG/ML, INDICATION ORAL SUSPENSION Quantity: 1120 DOMPERIDONE, DOSAGE 10 MG Quantity: 7200 SCOPOLAMINE BUTYLBROMIDE, DOSAGE 10 MG/ML, INDICATION FOR ORAL SOLUTION Quantity: 900 SCOPOLAMINE BUTYLBROMIDE, DOSAGE 20 MG/ML, INJECTABLE SOLUTION INDICATIONS ...
Documents
Tender Notice